OSTX · OS Therapies Inc
$1.53
+0.03 (+2.00%)
At close · Jul 17
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed May 18, 2026
Market Cap
$68.14M
Shares
44,538,106
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$28.75M
-223.7%
FY2025
Diluted EPS
-$0.98
+23.4%
FY2025
Operating Cash Flow
-$14.24M
-95.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $22.4M | $16.36M | $2.84M | $3.22M | |
| $11.47M | $12.34M | $3.97M | $1.13M | |
| — | $363.09K | $2780 | — | |
| -$33.87M | -$28.71M | -$6.81M | -$4.34M | |
| — | — | $2.05M | $3.45M | |
| $228 | $249 | — | $2 | |
| -$1.4M | -$48.14K | -$2.07M | -$3.45M | |
| -$35.27M | -$28.75M | -$8.88M | -$7.79M | |
| -$35.27M | -$28.75M | -$8.91M | -$7.92M | |
| USD/shares | — | -$0.98 | -$1.28 | -$1.46 |
| USD/shares | — | -$0.98 | -$1.28 | -$1.46 |
| shares | — | — | 12.38M | 5.43M |
| shares | — | 29.25M | 6.95M | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.75×
EV/EBIT
—
Biotechnology median 26.36×
P/E (TTM)
—
Biotechnology median 7.37×
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Chief Operating Decision Maker | -$28,705,701 | -$6,813,846 | — |
| All Other Segments | — | — | -$4,342,645 |